Supervisor:Ministry of Education of the People's Republic of ChinaSponsor:Sichuan University Editor-in-chief:LUO Fengming Publishing period:
Monthly
ISSN:1002-0179CN:51-1356/R
MELIA W M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etoposide (VP-16) with adriamycin[J]. Cancer,1983,51:206..
8.
SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1):s143..
9.
PORTA C, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricalcium are active to treat unresectable hepatocellular ]. Oncology,1995,52:487.
10.
KHOO K S, AU E, KOO W H, et al. PhaseⅡ study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J]. Pro Am Soc Clin Oncol,1996,15:226..
1. [carcinoma patients: preliminary results of a phase study[J1]楊永紅,王安群,許榮雙.原發性肝細胞性肝癌與胃腺癌并存一例[J].四川腫瘤防治,1997,10:4..
7. MELIA W M, JOHNSON P J, WILLIAM S R, et al. Induction of remission in hepatocellular carcinoma: a comparison of etoposide (VP-16) with adriamycin[J]. Cancer,1983,51:206..
8. SHIU W C T. Primary liver cancer in Hongkong[J]. Cancer Chemother Pharmacol,1992,31(Suppl 1):s143..
9. PORTA C, MORONI M, NASTASI G, et al. 5-fluorouracil and leucovoricalcium are active to treat unresectable hepatocellular ]. Oncology,1995,52:487.
10. KHOO K S, AU E, KOO W H, et al. PhaseⅡ study of NSC 620212-doxorubicin HCL liposome injection (lipodox) in hepatocellular carcinoma (HCC)[abstract][J]. Pro Am Soc Clin Oncol,1996,15:226..